Read + Share
Amedeo Smart
Independent Medical Education
Lin DS, Yu AL, Lo HY, Lien CW, et al. Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors. Diabetologia 2022 Aug 9. pii: 10.1007/s00125-022-05772.PMID: 35945333
Email
LinkedIn
Facebook
Twitter
Privacy Policy